PCBs have risen this much, but you're telling me to look more? | Kim Min-soo, Lemon Research CEO [Double Up]

Watch on YouTube ↗  |  May 26, 2026 at 01:28  |  19:24  |  3PRO TV (삼프로TV)
Speakers
Kim Min-soo — CEO

Summary

Kim Min-soo, CEO of Lemon Research, argues that AI hardware, especially Korean PCB/substrate companies, still has upside despite recent gains. He recommends rotating from Nvidia into CPU-focused US stocks like AMD and Intel as AI shifts to inference. He also advises reducing Korean biotech positions, as the sector lacks a catalyst.

  • Kim Min-soo emphasizes that AI hardware remains the core investment theme.
  • He recommends Korean substrate stocks (Samsung Electro-Mechanics, LG Innotek) as undervalued vs. Taiwanese peers.
  • He suggests reducing Nvidia and increasing exposure to AMD, Intel, Qualcomm, ARM, Dell, and HP.
  • He views Korean biotech as needing a major catalyst and advises reducing holdings on rebounds.
  • He expects the KOSPI to weaken early in June then strengthen later.
  • He advises against chasing non-leading sectors and to stick with AI hardware.
Trade Ideas
Rotate from Nvidia to CPU stocks.
As AI shifts from training to inference, the relative importance of CPUs versus GPUs will increase. US CPU-related companies like AMD, Intel, Qualcomm, and ARM will benefit more than Nvidia. Nvidia should be reduced to fund these positions. Dell and HP as system integrators also benefit.
Rotate from Nvidia to CPU stocks.
As AI shifts from training to inference, the relative importance of CPUs versus GPUs will increase. US CPU-related companies like AMD, Intel, Qualcomm, and ARM will benefit more than Nvidia. Nvidia should be reduced to fund these positions. Dell and HP as system integrators also benefit.
Korean substrates still cheap vs Taiwan.
Korean PCB/substrate companies still have significant upside compared to Taiwanese peers because capacity expansion plans (e.g., TLB, Samsung Electro-Mechanics targeting 2028) indicate structural demand for AI substrates. Despite recent price gains, the sector remains undervalued relative to global competitors and will continue to benefit from AI hardware growth.
Reduce Korean biotech, needs catalyst.
Korean biotech stocks lack earnings momentum and need a major catalyst (e.g., clinical success from a large-cap company) to rally. The current rebound due to falling interest rates is not sustainable. Investors should reduce biotech positions on any strength and move to leading sectors.
Up Next

This 3PRO TV (삼프로TV) video, published May 26, 2026, features Kim Min-soo discussing NVDA, AMD, INTC, QCOM, ARM, DELL, HPQ, 009150.KS, 011070.KS, Korean PCB/substrate sector, Korean biotech sector. 4 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Kim Min-soo  · Tickers: NVDA, AMD, INTC, QCOM, ARM, DELL, HPQ, 009150.KS, 011070.KS, Korean PCB/substrate sector, Korean biotech sector